Orlando Health UF Health Cancer Center
Address: 22 W. Underwood St.
Orlando, FL 32806
Rebecca Lynn Moroose, MD, is board-certified in medical oncology by the American Board of Internal Medicine and serves as the Director of the Office of Clinical Trials and the Medical Director for Cancer Genetics at Orlando Health UF Health Cancer Center.
Dr. Moroose received her medical degree from the University of Connecticut School of Medicine in Farmington. She completed an internship in internal medicine at the University of Maryland Medical Center in Baltimore before returning to the University of Connecticut Health Center to complete her residency in internal medicine, where she served as chief medical resident. Dr. Moroose also completed her hematology/oncology fellowship at the University of Connecticut Health Center.
Prior to joining Orlando Health UF Health Cancer Center, Dr. Moroose worked at the Florida Hospital Cancer Center, where she served as medical director. She served on the founding faculty as an assistant professor of medicine at the University of Central Florida College of Medicine, where she was the director of the Psychosocial Issues in Healthcare Module, and served as the co-chair of the Hematology/Oncology Module and the Focused Individualized Research Module. She received the University of Central Florida College of Medicine Visionary Award, selected by the Class of 2013. She currently has an appointment as associate professor of medicine at the University of Central Florida College of Medicine and is invited to lecture on cancer, coagulation and genetics.
She has published book chapters as well as many published refereed articles. She is an invited columnist for Orange Appeal magazine. She is a member of the American Society of Clinical Oncology and currently serves on the Parents Council of Rollins College.
Cancer Genetics Center Opens At UF Health Cancer Center; Orlando Health Providing Road Map For High-Risk Patients
The specialized center is streamlined to care for high-risk patients, including those with genetic links to cancer.Read More.